Danish Study Links Diabetes Drug Ozempic to Increased Risk of Severe Eye Condition
2024-12-17
Two independent studies from the University of Southern Denmark (SDU) reveal that patients with type 2 diabetes treated with Ozempic have a significantly higher risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), a condition causing severe and permanent vision loss. These large-scale studies, based on Danish registries, found Ozempic more than doubles the risk of NAION. Researchers recommend doctors and patients discuss the benefits and risks of Ozempic, suggesting treatment cessation if NAION is detected in one eye.